217 related articles for article (PubMed ID: 15316460)
1. Prevention of restenosis after coronary angioplasty.
Karthikeyan G; Bhargava B
Curr Opin Cardiol; 2004 Sep; 19(5):500-9. PubMed ID: 15316460
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-eluting stents in coronary artery disease.
Nawarskas JJ; Osborn LA
Am J Health Syst Pharm; 2005 Nov; 62(21):2241-51. PubMed ID: 16239414
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of drug-eluting stents: the next revolution.
Moses JW; Kipshidze N; Leon MB
Am J Cardiovasc Drugs; 2002; 2(3):163-72. PubMed ID: 14727979
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
9. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
11. Drug-coated balloons for coronary and peripheral interventional procedures.
Wöhrle J
Curr Cardiol Rep; 2012 Oct; 14(5):635-41. PubMed ID: 22825918
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis.
Doggrell SA
Expert Opin Pharmacother; 2004 Nov; 5(11):2209-20. PubMed ID: 15500367
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
Stone GW; Ellis SG; Cannon L; Mann JT; Greenberg JD; Spriggs D; O'Shaughnessy CD; DeMaio S; Hall P; Popma JJ; Koglin J; Russell ME;
JAMA; 2005 Sep; 294(10):1215-23. PubMed ID: 16160130
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
15. Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study).
Wong SC; Hong MK; Ellis SG; Buchbinder M; Reisman M; DeLago A; Kellett M; Popma JJ; Russell ME; Mehran R; Moses JW; Stone GW
Am J Cardiol; 2005 May; 95(9):1043-8. PubMed ID: 15842968
[TBL] [Abstract][Full Text] [Related]
16. [Stents in interventional cardiology].
Grinius V; Navickas R; Unikas R
Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
[TBL] [Abstract][Full Text] [Related]
17. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
